Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | 0.00% | -3.80% | -14.51% |
Evolution of the average Target Price on Achilles Therapeutics plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Achilles Therapeutics plc
Chardan Research | |
Piper Sandler | |
BofA Securities | |
Oppenheimer | |
Chardan | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- ACHL Stock
- Consensus Achilles Therapeutics plc